KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Tax Provisions (2020 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Tax Provisions for 3 consecutive years, with -$198000.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Tax Provisions rose 98.66% year-over-year to -$198000.0, compared with a TTM value of -$71000.0 through Dec 2023, up 99.55%, and an annual FY2025 reading of -$837000.0, down 74.74% over the prior year.
  • Tax Provisions was -$198000.0 for Q4 2023 at Ginkgo Bioworks Holdings, down from -$22000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $159000.0 in Q2 2021 and bottomed at -$14.8 million in Q4 2022.
  • Average Tax Provisions over 3 years is -$1.6 million, with a median of -$93500.0 recorded in 2021.
  • The sharpest move saw Tax Provisions plummeted 2062.52% in 2022, then soared 98.66% in 2023.
  • Year by year, Tax Provisions stood at -$683000.0 in 2021, then tumbled by 2062.52% to -$14.8 million in 2022, then skyrocketed by 98.66% to -$198000.0 in 2023.
  • Business Quant data shows Tax Provisions for DNA at -$198000.0 in Q4 2023, -$22000.0 in Q3 2023, and $67000.0 in Q2 2023.